The company closed its plan on December 19, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.98 CNY | +1.53% | -0.85% | -5.41% |
14/05 | Yifan Pharmaceutical Unit Gets Authorization to Sell Circulation Supplement in Singapore | MT |
25/04 | Yifan Unit's Allergy Drug Passes China Regulatory Test, Stock Price Jumps | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.41% | 235.12Cr | |
+21.28% | 4.44TCr | |
+24.60% | 2.3TCr | |
+18.18% | 1.51TCr | |
+12.87% | 1.31TCr | |
+44.67% | 1.19TCr | |
-8.33% | 698.92Cr | |
-0.05% | 678.76Cr | |
-8.87% | 572.55Cr | |
+12.22% | 551.54Cr |
- Stock Market
- Equities
- 002019 Stock
- News Yifan Pharmaceutical Co., Ltd.
- Yifan Pharmaceutical Co., Ltd.'s Equity Buyback announced on August 31, 2023, has closed with 2,412,900 shares, representing 0.2% for CNY 38 million.